-
Article | 2025.03.10
Observing standards of professional conduct and scientific integrity
Guaranteeing the scientific integrity, compliance and impartiality of research is crucial, especially at a time when scientific methods and findings are coming under increasing public scrutiny. At the Institut Pasteur, the Research Integrity Officer (RIS) works with the Committee for Research Integrity and Conciliation (CISC) and the Ethics and Compliance Committee (CDC) to oversee compliance...
-
Vidéo | 2025.03.24
Understanding depression
30% of people suffering from depression are resistant to antidepressants. Why?With her team, Mariana Alonso, a researcher in the Perception and Action Unit and head of the Emotional Circuits team at the Institut Pasteur, has identified a key mechanism involved in this disorder. During a depressive episode, the amygdala, a region of the brain that processes emotions, functions differently:Less...
-
Fiche maladie | 2017.09.28
Tuberculosis
Tuberculosis (TB) is an infectious disease that generally affects the lungs, caused by the Mycobacterium tuberculosis bacterium. It is highly contagious and is spread through the air when infected people cough or sneeze. Although tuberculosis can be fatal, it is often treatable and can be prevented if diagnosed and treated correctly.
-
Document de presse | 2025.03.17
Hepatitis B: new rapid diagnostic test to halt mother-to-child transmission
Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid diagnostic test to identify pregnant women at elevated risk of transmitting hepatitis B to their babies. This diagnostic tool could help eliminate hepatitis B by preventing mother-to-child transmission during childbirth, especially in low- and middle-income countries. Hepatitis B is...
-
News | 2025.03.26
Training the Physician-Scientists of Tomorrow: Institut Pasteur MD-PhD Program
In the face of global health crises and growing public health challenges, strengthening the links between scientific research (both fundamental and applied) and clinical practice has become essential. Recognizing this need, the Institut Pasteur has launched the MD-PhD program as part of its “Pasteur 2030” strategic plan, aiming to engage the Institute in training physician-scientists who can...
-
News | 2025.03.20
An international scientific alliance to strengthen the fight against infectious diseases
The Institut Pasteur and UCSF-QBI celebrated an ongoing successful scientific collaboration today, which was initiated in March 2019, and expanded significantly during the pandemic. This alliance, formalized in October 2022, aimed at bolstering the fight against infectious diseases, has already spawned more than 20 research projects, a dozen publications in high-level journals, and numerous...
-
Document de presse | 2025.03.06
How AI will make it easier to anticipate future pandemics
In a Nature perspective paper, scientists across Africa, America, Asia, Australia, and Europe outline for the first time how Artificial Intelligence (AI) can transform the landscape of infectious disease research and improve pandemic preparedness. In the next five years, integrating AI into country response systems could save more lives by anticipating the location and trajectory of disease...
-
Article | 2023.02.23
One Health-Emerging Infectious Diseases Graduate School (1H-EID)
The new Graduate School "One Health in Emerging Infectious Diseases" (1H-EID) is entirely dedicated to EIDs with a multidisciplinary approach. This Graduate School offers a high-level educational program based on research, to train future researchers, health professionals and decision-makers.The aim of 1H-EID will be to form a community of frontline actors, researchers and decision-makers,all...
-
Article | 2020.08.13
The Institut Pasteur Innovation Accelerator
The main challenge for academics in the commercialization of important new discoveries is the technological development gap: the phase between inventions at an early stage and the stage that innovative technologies must reach to become viable and attractive candidates for licensing and commercialization.For high risk/high value products or for products with low commercial profitability, it is...
-
Vidéo | 2025.04.04
Debunking meningitis
Meningitis: warning signs!200 cases in France since January? Yes, but... This figure concerns invasive meningococcal infections, a 25-year record. But not all of them are meningitis!Dr Samy Taha, medical researcher at the CNR des Méningocoques, reminds us of the importance of prevention and rapid screening to limit serious forms of the disease.Symptoms to watch out for :High fever and intense...
